BLUTTESTVORRICHTUNG

Patent europeic · EP4261539 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4261539
Numer da la dumonda
EP22813388
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
24-02-2022
Publitgà
18-10-2023
Concedì
11-09-2024
La protecziun finescha il pli tard
23-02-2042
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
G01N 33/52 (2006.01)
Dumonda PCT
PCT/JP2022/007627 24.02.2022
Publicaziun PCT
WO2023/162095 31.08.2023
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 23-07-2025

    Midada

    Published in Swissreg on 23.07.2025

  3. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  4. 17-09-2024

    Represchentant inscrit

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug

    Published in Swissreg on 17.09.2024

  5. 11-09-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

Partidas

Possessur

Cellspect Co., Ltd.

2-4-23, Kitaiioka, Morioka-shi, Iwate 020-0857, JP

Represchentant

Dennemeyer AG

Bahnhofstrasse 23, 6300 Zug

Inventur

KIM, Seung Kyum

Morioka City, Iwate 0200857, JP

EDURA, Tomohiko

Morioka City, Iwate 0200857, JP

ITO, Takashi

Morioka City, Iwate 0200857, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.